loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Risedronate Sodium API

    Client Email Product
    Menu

    Risedronate Sodium API

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 905Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20835 / DOSAGE - TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RISEDRONATE SODIUM(UNII: OFG5EXG60L)
    (risedronic acid - UNII:KM2Z91756Z)     		RISEDRONATE SODIUM5mg | 30mg | 35mg | 75mg | 150mg

    Inactive Ingredients

    Ingredient Name
    Warner Chilcott Pharmaceuticals Inc.
    Actavis Pharma, Inc.
    Allergan, Inc.
    ALUMINUM OXIDE(LMI26O6933)  
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSPOVIDONE(2S7830E561) 
    CROSPOVIDONE(68401960MK)  
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE RED(1K09F3G675)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) 
    HYDROXYPROPYL CELLULOSE(RFW2ET671P)  
    HYPROMELLOSE(3NXW29V3WO)  
    HYPROMELLOSES(3NXW29V3WO) 
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    POLYETHYLENE GLYCOL(3WJQ0SDW1A)  
    POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) 
    SILICON DIOXIDE(ETJ7Z6XBU4)
    TITANIUM DIOXIDE(15FIX9V2JP)